The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Colorectal cancer screening with blood-based tests: Estimated impact of a 1-, 2-, or 3-year screening interval compared with annual FIT and triennial mt-sDNA strategies.
 
A. Mark Fendrick
Stock and Other Ownership Interests - Health at Scale Technologies; Sempre Health; Silver Fern Healthcare; Wellth
Consulting or Advisory Role - Abbvie; Amgen; Bayer; CareFirst BlueCross BlueShield; Centivo; Community Oncology Alliance; Emblem Health; HealthCorum; Hygieia; Johnson & Johnson; MedZed; Mercer; Merck; Phathom Pharmaceuticals; ProtonIntel; RA Capital
Research Funding - Arnold Ventures; Centers for Medicare & Medicaid Services; National Pharmaceutical Council; Patient-Centered Outcomes Research Institute (PCORI); PhRMA Foundation; Robert Wood Johnson Foundation
 
John B. Kisiel
Honoraria - MedaCorp
Consulting or Advisory Role - Exact Sciences (Inst)
Research Funding - Exact Sciences (Inst)
Patents, Royalties, Other Intellectual Property - Exact Sciences (Inst)
Travel, Accommodations, Expenses - Exact Sciences (Inst)
 
Derek W. Ebner
No Relationships to Disclose
 
A. Burak Ozbay
Employment - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
 
Vahab Vahdat
Employment - Exact Sciences
Stock and Other Ownership Interests - Exact Sciences
 
Chris Estes
Employment - Exact Sciences
 
Paul J. Limburg
Employment - Exact Sciences
Leadership - Exact Sciences (Inst)
Stock and Other Ownership Interests - Exact Sciences
Consulting or Advisory Role - Exact Sciences (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boston Scientific (Inst); Exact Sciences (Inst); Fujinon (Inst); Ironwood Pharmaceuticals (Inst); Thorne Research (Inst)
Patents, Royalties, Other Intellectual Property - Prior to becoming an Exact Sciences employee in July 2022, Dr. Limburg served as Chief Medical Officer for Screening at Exact Sciences through a contracted services agreement with Mayo Clinic. Dr. Limburg and Mayo Clinic had contractual rights to receive